Abstract: The invention relates to methods and pharmaceutical compositions for inhibiting or preventing preterm birth, inhibiting or delaying cervical ripening, inhibiting myometrial contractility and treating or inhibiting uterine contractility disorders. The methods comprise administering an effective amount of a composition comprising steroid hormones such as soluble progesterone.

Abstract: Briefly, in accordance with one embodiment, a method of identifying marked content is described.

Abstract: This invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof; as well as a method for treating obesity, a method for treating diabetes, and a pharmaceutical composition.

Abstract: Techniques described herein are generally related to steganalysis of suspect media. Steganalysis techniques may include receiving instances of suspect media as input for steganalytic processing. A first set of quantized blocks of data elements may be identified within the media, with this first set of blocks being eligible to be embedded with steganographic data. A second set of quantized blocks of data elements may be identified within the media, with this second set of blocks being ineligible to be embedded with steganographic data. The steganalysis techniques may requantize the first and second blocks. In turn, these techniques may compare statistics resulting from requantizing the first block with statistics resulting from requantizing the second block. The steganalysis techniques may then assess whether the first block of data elements is embedded with steganographic features based on how the statistics of the second blocks compare with the statistics of the first blocks.

Abstract: A method of hiding data comprising creating a histogram of an attribute of a first data set. The histogram includes occurrences of the attribute. Two adjacent occurrences are selected where a count of one of the two adjacent occurrences is zero. A second data set is embedded in data of the first data set associated with the selected adjacent occurrences.

Abstract: Briefly, in accordance with one embodiment, a method of identifying marked images based at least in part on frequency domain coefficient differences is disclosed.

Abstract: Embodiments related to data hiding using wavelet transforms and histogram shifting are disclosed.

Abstract: Techniques are generally described to determine whether a JPEG image has undergone two compressions. Probabilities can be computed for the first digits of quantized DCT (discrete cosine transform) coefficients from a set of AC (alternate current) modes to detect or determine whether the JPEG image has undergone two compressions. The set of AC modes may include a predetermined number of distinguishable AC modes where a distinguishable AC mode may be an AC mode in which a second quantization step (QS2) is not an integer multiple of the first quantization step (QS1). Classifiers may be created during a training process, and later may be used to assist in determining whether a suspect JPEG image has undergone two compressions. When the classifiers support a multi-classification system, described detection techniques may also be arranged to determine a primary quality factor for the double compressed JPEG image.

Abstract: A method of processing images, including: training an image classifier to obtain a trained classifier, the training including: forming multiple prediction error sets from neighboring samples of a set of known images, a prediction error for each pixel of the error sets being formed by subtracting a predicted pixel value from an original value; thresholding the formed prediction error sets; and training the image classifier using the thresholded prediction error sets.

Abstract: Techniques are generally described for detecting double JPEG compression in images. Example detection techniques of double JPEG compression may include receiving JPEG images for analysis and extracting 2-dimensional (2-D) arrays of JPEG coefficients from the images. 2-D difference arrays may be generated from the array of JPEG coefficients, with the entries in the difference array reflecting relative changes in values of pairs of entries in the array of JPEG coefficients. The detection techniques also model the difference arrays using random processes, and evaluate whether the random processes reveal statistical artifacts in the JPEG images. These statistical artifacts result from double JPEG impression performed on the JPEG images.

Abstract: The subject matter disclosed herein relates to techniques for detecting tampering of digital image data.

Abstract: Methods for reversible data hiding are disclosed herein. These methods may be applied to images for reversible image data hiding. In one embodiment, a method for reversible data hiding comprises identifying carrier data having a plurality of components and establishing prediction-errors for each of the components of the carrier data. A first threshold and a second threshold are established. The prediction-errors of the components are evaluated against the first threshold to identify components for possible hiding. The components identified for possible hiding are evaluated against the second threshold to identify components for hiding. To-be embedded data is embedded into the carrier data identified for hiding to create marked data. The marked data is evaluated for overflow or underflow. If overflow or underflow is detected, histogram modification is performed. Marked data is then established.

Abstract: Disclosed are nicotinamide compounds of Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof. Also disclosed are methods of using such compounds in the treatment of at least one Btk associated condition, such as, for example, inflammatory disease, and pharmaceutical compositions comprising such compounds.

Abstract: The present invention is directed to compounds of formula (I) or a pharmaceutically acceptable salt thereof; wherein A is (1); X is selected from CH, CF and N; R5 is selected from H, C1-C6 alkyl, C1-C6 fluoroalkyl, and —OR12; R9 is selected from H —NR13C(O)R14 and —C(O)NR10R11; R12 is selected from H, C1-C6 alkyl and C3-C6 cycloalkyl, for use as inhibitors of the DPP-IV enzyme in the treatment or prevention of conditions including Type II diabetes.

Abstract: Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are useful as kinase modulators, including Btk modulation.

Abstract: The present invention is directed to compounds of formula (I): or a pharmaceutically acceptable salt thereof; wherein A is (II); X is selected from CH, CF and N, R8 is selected from H, C1-C6 alkyl, aryl, heteroaryl, C1-C6 alkylaryl, C1-C6 alkylheteroaryl, C2-C6 alkyl-O—C1-C6 alkyl, C1-C6 haloalkyl, hydroxy C2-C6 alkyl, —C(O)R9 and —SO2R9, or R7 and R8 combine to form (III), (IV); W is selected from CR1O and CR15, R1O is selected from H, halo, —C(O)NR13R14, C1-C6 alkyl, aryl, heteroaryl, C1-C6 alkylaryl, C1-C6 alkylheteroaryl, C1-C6 alkyl-O—C1-C6 alkyl and hydroxy C1-C6 alkyl; Het is a N-linked 5-membered heteroaryl ring optionally substituted with 1-3 substituents selected from methoxy, Cl, F, CH3, CF3, aryl, heteroaryl, C1-C4 alkylaryl or C1-C4 alkylheteroaryl, for use as inhibitors of the DPP-IV enzyme in the treatment or prevention of conditions including Type II diabetes.

Abstract: Briefly, embodiments of a method of identifying marked images, in which higher order statistical moments based at least in part on a JPEG array are employed, is described.

Abstract: Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are useful as kinase modulators, including Btk modulation.

Abstract: The present invention is directed to compounds of formula (I) or a pharmaceutically acceptable salt thereof; wherein A is (xx); X is selected from CH, CF and N, R5 is selected from H, C1-C6 alkyl, C1-C6 fluoroalkyl, and —OR12, R9 is selected from H and —C(O)NR1OR1 1, R12 is selected from H, C1-C6 alkyl and C3-C6 cycloalkyl for use as inhibitors of the DPP-IV enzyme in the treatment or prevention of conditions including Type II diabetes.

Abstract: Computer graphics may be detected in digital images by extracting a first set of features from an input digital image, extracting a second set of features from a prediction-error image derived from the input digital image, and applying a classification algorithm to the first set of features and the second set of features to determine if the combined sets of features indicate that the input digital image corresponds to computer graphics.